InvestorsHub Logo
Followers 169
Posts 13860
Boards Moderated 1
Alias Born 01/26/2016

Re: Nemesis18 post# 703074

Monday, 07/01/2024 4:54:48 PM

Monday, July 01, 2024 4:54:48 PM

Post# of 730111
Nemesis18,

The average cost for SOC treatment of GBM in the US was posted on this board a few years ago at about $135,000 I believe. That’s about what the L vaccine might cost and evidence suggests that the elderly do better on L when less or no chemo is involved, at least with rGBM. The question then becomes how about no chemo at an earlier stage for those not demonstrating benefit? Threatening to current makers of chemo right? What about Kat’s cure that didn’t need checkpoint inhibitors after 3rd surgery, at least initially. Another patient group threat. Then there is the combo patent grant. Another threat to reimbursement rate. Bottom line, the UK has horrendous survival numbers and UCLA, where L has been used for many years, has leading edge numbers and patient outcry will eventually be enough when there is real hope because if real results. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News